UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000051304
Receipt number R000058499
Scientific Title Construction of Eye Tracking and Feedback System (ETF System) for improving colorectal lesion detection
Date of disclosure of the study information 2023/07/01
Last modified on 2024/03/07 08:37:17

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Construction of Eye Tracking and Feedback System (ETF System) for improving colorectal lesion detection

Acronym

Construction of ETF System for improving colorectal lesion detection

Scientific Title

Construction of Eye Tracking and Feedback System (ETF System) for improving colorectal lesion detection

Scientific Title:Acronym

Construction of ETF System for improving colorectal lesion detection

Region

Japan


Condition

Condition

Colorectal polyp

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to construct the feedback system of endoscopist's visual gaze pattern in colonoscopy for improving adenoma detection and to optimize the system setting.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Number of adenoma per colonoscopy in the group with ETF System and the control group

Key secondary outcomes

Adenoma detection rate, Number of adenoma per colonoscopy in the right-sided colon, Adenoma detection rate in the right-sided colon, Sessile serrated lesion detection rate, Withdrawal time during colonoscopy, Visual gaze pattern distribution of endoscopist, Visual gaze pattern during treatment of colorectal polyp, Visual gaze velocity of endoscopist, etc.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Maneuver

Interventions/Control_1

ETF System equipped group 1 (wide region of interest for feedback)

Interventions/Control_2

ETF System equipped group 2 (middle region of interest for feedback)

Interventions/Control_3

ETF System equipped group 3 (narrow region of interest for feedback)

Interventions/Control_4

Control group (without ETF System)

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1. Those who undergoes the colonoscopy
2. Those whose performance status is 0,1 or 2
3. Those who recieves an explanation about the entry for this study and obtain his/her consent in a document

Key exclusion criteria

1. Those who received colorectal surgery (Exclude an appendix excision)
2. Those with inflammatory bowel disease (Ulcerative colitis, Crohn disease and Behcet disease)
3. Those with hereditary or non-hereditary polyposis
4. Those with hereditary nonpolyposis colorectal cancer (Lynch syndrome)
5. Those with severe diverticulum that infers safe examination
6. Those who cannot take pretreatment medication before colonoscopy
7. Those who has an allergy for pretreatment medication or sedative agent
8. Those whose colorectal adenoma or colorectal cancer has been already identified
9. Those who is pregnant
10.Those who is breastfeeding
11.Those whose consent cannot be obtained
12.Those who is confirmed to be inappropriate for participation by the doctor in charge of the study
13.Those who has already been enrolled for this study

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Sho
Middle name
Last name Suzuki

Organization

International University of Health and Welfare Ichikawa Hospital

Division name

Gastroenterology and Hepatology

Zip code

272-0827

Address

6-1-14 Konodai Ichikawa-City Chiba

TEL

047-375-1111

Email

s.sho.salubriter.mail@gmail.com


Public contact

Name of contact person

1st name Mizuki
Middle name
Last name Nagai

Organization

International University of Health and Welfare Ichikawa Hospital

Division name

Gastroenterology and Hepatology

Zip code

272-0827

Address

6-1-14 Konodai Ichikawa-City Chiba

TEL

047-375-1111

Homepage URL

https://ichikawa.iuhw.ac.jp

Email

nagaim@iuhw.ac.jp


Sponsor or person

Institute

International University of Health and Welfare Ichikawa Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the promotion of science

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)

None


IRB Contact (For public release)

Organization

Ethics Comittee of Chiba area of International Universiy of Health and Welfare

Address

4-3 Kodunomori Narita-City Chiba

Tel

0476-20-7708

Email

rinri_md@iuhw.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国際医療福祉大学市川病院


Other administrative information

Date of disclosure of the study information

2023 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

200

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2023 Year 03 Month 01 Day

Date of IRB

2023 Year 03 Month 14 Day

Anticipated trial start date

2023 Year 07 Month 01 Day

Last follow-up date

2023 Year 12 Month 09 Day

Date of closure to data entry

2023 Year 12 Month 09 Day

Date trial data considered complete

2023 Year 12 Month 31 Day

Date analysis concluded

2024 Year 01 Month 31 Day


Other

Other related information



Management information

Registered date

2023 Year 06 Month 09 Day

Last modified on

2024 Year 03 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058499


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name